134 related articles for article (PubMed ID: 2656927)
1. Clinical impact of newer quinolones: influence on normal microflora.
Nord CE; Edlund C
J Chemother; 1989 Feb; 1(1):18-23. PubMed ID: 2656927
[TBL] [Abstract][Full Text] [Related]
2. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
Edlund C; Nord CE
Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
[TBL] [Abstract][Full Text] [Related]
3. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Edlund C; Nord CE
Infection; 1988; 16(1):8-12. PubMed ID: 3283041
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the oropharyngeal and gastrointestinal microflora by ciprofloxacin: microbiological and clinical consequences.
Edlund C; Nord CE
Scand J Infect Dis Suppl; 1989; 60():98-103. PubMed ID: 2667112
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
6. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
[TBL] [Abstract][Full Text] [Related]
7. [Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital].
Fernández Fernández A; Lantero Benedito M; Gastañares Hernando MJ; Undabeitia Santisteban E; Fernández Santos F; Castaño Rodríguez A; Gil Fabra J; Martínez Castellanos F; Otero Mauricio G
Actas Urol Esp; 1994 Jun; 18(6):634-8. PubMed ID: 7942213
[TBL] [Abstract][Full Text] [Related]
8. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics.
Edlund C; Bergan T; Josefsson K; Solberg R; Nord CE
Scand J Infect Dis; 1987; 19(1):113-21. PubMed ID: 3563419
[TBL] [Abstract][Full Text] [Related]
9. Effect of new quinolones on the human gastrointestinal microflora.
Nord CE
Rev Infect Dis; 1988; 10 Suppl 1():S193-6. PubMed ID: 3279492
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
Nix DE; DeVito JM
Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora.
Nord CE; Heimdahl A; Kager L
Scand J Infect Dis Suppl; 1986; 49():64-72. PubMed ID: 3547626
[TBL] [Abstract][Full Text] [Related]
12. Bacterial resistance to norfloxacin and other newer quinolones: pattern and prospects.
Nalin DR
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S55-61. PubMed ID: 3280327
[No Abstract] [Full Text] [Related]
13. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.
Pérez-Trallero E; Urbieta M; Jimenez D; García-Arenzana JM; Cilla G
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):349-51. PubMed ID: 8354301
[TBL] [Abstract][Full Text] [Related]
14. Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.
Boerema JB; Olthof BJ; van Saene HK
Scand J Infect Dis Suppl; 1986; 48():27-31. PubMed ID: 3095916
[TBL] [Abstract][Full Text] [Related]
15. [Influence of new quinolones on superoxide anion generation of polymorphonuclear leukocytes].
Mitani H; Kiyota H
Kansenshogaku Zasshi; 1992 Jan; 66(1):59-65. PubMed ID: 1328418
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolones reviewed.
Drug Ther Bull; 1993 Aug; 31(18):69-72. PubMed ID: 8404463
[No Abstract] [Full Text] [Related]
17. [Quinolone resistance of Escherichia coli strains isolated from urinary tract infections].
Agulla A; Montes I
Enferm Infecc Microbiol Clin; 1994; 12(6):322. PubMed ID: 8080877
[No Abstract] [Full Text] [Related]
18. The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin.
Muranaka K; Greenwood D
J Antimicrob Chemother; 1988 May; 21(5):545-54. PubMed ID: 3134318
[TBL] [Abstract][Full Text] [Related]
19. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
Hooper DC; Wolfson JS
Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
[No Abstract] [Full Text] [Related]
20. Increasing rates of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens.
Desgrandchamps D; Munzinger J
Antimicrob Agents Chemother; 1989 Apr; 33(4):595-6. PubMed ID: 2729954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
